Zinc oxide nanoparticles exhibit anti-cancer activity against human cell lines

Bindu Sadanandan,P. Murali Krishna,Mamta Kumari,V Vijayalakshmi,B.M. Nagabhushana,Subrahmanyam Vangala,Himanshu Kumar Singh,B. R. Divya Swaroopa,V. Megala,P Murali Krishna,V. Vijayalakshmi,B.R. Divya Swaroopa
DOI: https://doi.org/10.1016/j.molstruc.2024.137723
IF: 3.841
2024-02-24
Journal of Molecular Structure
Abstract:Zinc oxide nanoparticles have garnered tremendous interest in bio and nanomedical applications and more so in cancer research. In the present work, zinc oxide nanoparticles were synthesized using the solution combustion method and characterized by UV–vis spectroscopy, FTIR, XRD, SEM and EDX. The infrared spectrum of the synthesized nanoparticles had a peak at 547 cm −1 which indicated the elongation frequency of the zinc bond to oxygen. The XRD spectrum was confirmed with the ICDD Data Card No: 36-1451 for zinc oxide and the average size of zinc oxide nanoparticles was estimated to be 17.51 nm. Scanning electron microscopy confirmed the presence of zinc oxide nanoparticles as Zincite with a hexagonal structure having an average diameter of 30.95 nm. The DNA binding interactions of the nanoparticles were studied using the absorption titration method. The nanoparticles could bind via the non-intercalation mode with a binding efficiency of 3.563×10 5 M −1 . The synthesized zinc oxide nanoparticles exhibited cytotoxic activity against the mammalian cancer cell lines tested with the calculated IC50 values being 3.66 μgmL −1 for MCF-7 (Breast), 2.91 μgmL −1 for LN-18 (Glioblastoma–Brain), 23.14 μgmL −1 for A-549 (Lung) and 94.33 μgmL −1 for SHSY-5Y (Neuroblastoma–Bone). The highest cell death was observed for LN-18 glioblastoma cells of the brain. The study demonstrated a simple and conventional method of synthesis of zinc oxide nanoparticles that have demonstrated anticancer activity as evidenced by the in vitro cell viability assays. The outcome of this study could be applied to develop zinc oxide nanoparticles as anticancer agents with further validation in vivo.
chemistry, physical
What problem does this paper attempt to address?